iTeos Belgium
ActiveiTeos Belgium has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-5.06M) and a net result of €-93.46M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 9% of 188 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
32
/ 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-100
Solvency14▼-75
Growth22▼-30
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.56 against 2.0 in 2024; short-term debt: 108.7% and cash: 3.2% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Ten signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-10.9%
Return on assets
-201.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €-5.06M
neutral · A punctual record breaks
This company filed 9 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-09-2026, 45 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
45 d late
2024
57 d early
2023
62 d early
2022
60 d early
2021
58 d early
2020
57 d early
2019
54 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€32.54M▲ 205%
2023 · €10.69M
2021: €292.50M
2022: €227.05M
2023: €10.69M
2021 → 2024
EBIT margin
-99.8%▲ 213.5pp
2023 · -313.4%
2021: 87.2%
2022: 78.2%
2023: -313.4%
2021 → 2024
Net result
€-93.46M
2024 · €40.83M
2018: €-14.85M
2019: €-11.61M
2020: €-4.93M
2021: €258.82M
2022: €190.00M
2023: €-15.13M
2024: €40.83M
2018 → 2025
Working capital
€-22.37M
2024 · €39.82M
2018: €19.05M
2019: €23.42M
2020: €22.58M
2021: €46.64M
2022: €39.34M
2023: €44.59M
2024: €39.82M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€292.50M-€227.05M▼ 22.4%€10.69M▼ 95.3%€32.54M▲ 205%
Equity€296.40M-€483.76M▲ 63.2%€464.84M▼ 3.9%€91.01M▼ 80.4%€-5.06M
Operating result€255.01M-€177.65M▼ 30.3%€-33.49M€-32.49M▲ 3.0%€-96.20M▼ 196%
Net result€258.82M-€190.00M▼ 26.6%€-15.13M€40.83M€-93.46M
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €96.20M in 2025 against €32.49M in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €46.30M
Fixed assets
€18.32M▼ 70.8%
Current assets
€27.98M▼ 64.8%
Key figures and ratios
EBITDA
€-62.16M▼
2024 · €13.51M
Cash flow
€-59.43M▼
2024 · €86.83M
Solvency
-10.9%▼
2024 · 64.0%
Current ratio
0.56▼
2024 · 2.00
Quick ratio
0.56▼
2024 · 2.00
Debt / equity
-10.14▼
2024 · 0.56
ROA
-201.9%▼
2024 · 28.7%
Interest coverage
-89.10▼
2024 · 150.57
Debt
€51.36M▲
2024 · €51.20M
Debt ≤ 1 year
€50.35M▲
2024 · €39.70M
Income taxes
€-1.35M▲
2024 · €-2.53M
Staff costs
€40.25M▲
2024 · €25.37M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€142.21M€46.30M▼
Formation expenses20€0-
Fixed assets21/28€62.69M€18.32M▼
Intangible fixed assets21€57.97M€18.16M▼
Tangible fixed assets22/27€4.57M-
Plant, machinery and equipment23€1.46M-
Furniture and vehicles24€162k-
Other tangible fixed assets26€2.81M-
Assets under construction and advance payments27€139k-
Financial fixed assets28€151k€156k▲
Other financial fixed assets284/8€151k€156k▲
Amounts receivable and cash guarantees285/8€151k€156k▲
Current assets29/58€79.52M€27.98M▼
Amounts receivable after more than one year29€325k-
Other amounts receivable291€325k-
Amounts receivable within one year40/41€52.18M€18.64M▼
Trade receivables40€14.04M€10.91M▼
Other amounts receivable41€38.14M€7.73M▼
Current investments50/53€18.24M€5.71M▼
Other investments51/53€18.24M€5.71M▼
Cash at bank and in hand54/58€2.59M€1.50M▼
Deferred charges and accrued income490/1€6.19M€2.14M▼
Equity and liabilities
Total equity and liabilities10/49€142.21M€46.30M▼
Equity10/15€91.01M€-5.06M▼
Contributions10/11€46.32M€46.32M=
Capital10€9.13M€9.13M=
Issued capital100€9.13M€9.13M=
Uncalled capital101€0€0=
Outside capital11€37.18M€37.18M=
Share premium1100/10€37.18M€37.18M=
Reserves13€913k€913k=
Non-distributable reserves130/1€913k€913k=
Legal reserve130€913k€913k=
Profit (loss) carried forward14€40.83M€-52.63M▼
Investment grants15€2.95M€333k▼
Amounts payable17/49€51.20M€51.36M▲
Amounts payable after more than one year17€6.35M-
Other amounts payable178/9€6.35M-
Amounts payable within one year42/48€39.70M€50.35M▲
Trade debts44€32.34M€9.12M▼
Suppliers440/4€32.34M€9.12M▼
Taxes, remuneration and social security45€5.59M€5k▼
Taxes450/3€124k€2k▼
Remuneration and social security454/9€5.46M€3k▼
Other amounts payable47/48€1.77M€41.23M▲
Accrued charges and deferred income492/3€5.14M€1.01M▼
Income statement
Code20242025
Operating income70/76A€148.51M€99.93M▼
Turnover70€32.54M-
Own construction capitalised72€57.56M€39.32M▼
Other operating income74€58.41M€60.61M▲
Operating charges60/66A€180.99M€196.13M▲
Services and other goods61€109.62M€71.90M▼
Remuneration, social security and pensions62€25.37M€40.25M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€46.00M€34.03M▼
Other operating charges640/8€2k€7k▲
Non-recurring operating charges66A€807€49.94M▲
Operating profit (loss)9901€-32.49M€-96.20M▼
Financial income75/76B€71.55M€4.15M▼
Recurring financial income75€26.66M€4.15M▼
Income from financial fixed assets750€19.80M€723k▼
Other financial income752/9€6.86M€3.42M▼
Non-recurring financial income76B€44.89M-
Financial charges65/66B€757k€2.75M▲
Recurring financial charges65€757k€2.75M▲
Debt charges650€90k€698k▲
Other financial charges652/9€667k€2.06M▲
Profit (loss) for the period before taxes9903€38.31M€-94.81M▼
Income taxes67/77€-2.53M€-1.35M▲
Taxes670/3€14k€12k▼
Tax adjustments and reversals of tax provisions77€2.54M€1.36M▼
Profit (loss) for the period9904€40.83M€-93.46M▼
Profit (loss) for the period to be appropriated9905€40.83M€-93.46M▼
Appropriation of the result
Profit (loss) to be appropriated9906€452.34M€-52.63M▼
Profit (loss) brought forward from the previous period14P€411.51M€40.83M▼
Profit to be distributed694/7€411.51M-
Return on contributions (dividend)694€411.51M-
Social balance
Average headcount (FTE)9087128.177.5▼
The notes to these accounts (78 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-09
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 45 days late
21-05
State Gazette act
Resignations & appointmentsBoard meeting · Director appointment · Power of attorney15 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Director appointment · Power of attorney15 facts ▸
- Board meeting, 2026-04-26
- Director appointment, Michel Detheux (Chief Executive Officer)
- Director appointment, Michael Hearne (Chief Financial Officer, Treasurer and Secretary)
- Director appointment, Ryan Cole (Chief Operating Officer)
- Director appointment, Stew Kroll (Chief Development Officer)
- Director appointment, Thomas Wei (Chief Business Officer)
- Power of attorney, Stew Kroll
- Power of attorney, Michael Hearne
- Power of attorney, Ryan Cole
- Power of attorney, Thomas Wei
- Power of attorney, Benoit Dethy
- Power of attorney, Michael Hearne
- +3 further facts in this act
2025
31-12
Financial
Weakest financial yearnet €-93.46M ▼329%
Net result drops to €-93.46M, the lowest in the series.
24-10
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment6 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment6 facts ▸
- General meeting, 2025-08-29
- Director resignation, Gilles Castaigne (administrateur)
- Director resignation, Benoit Dethy (administrateur)
- Director resignation, Philippe Brantegem (administrateur)
- Director appointment, Kevin Tang (administrateur)
- Director appointment, Michael Haerne (administrateur)
04-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Back to profitnet €40.83M
Net result €40.83M after one loss-making year.
16-12
State Gazette act
Resignations & appointmentsBoard meeting · Power of attorney2 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Power of attorney2 facts ▸
- Board meeting, 2024-11-25
- Power of attorney, Patricia Chevron
03-07
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor reappointment2 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor reappointment2 facts ▸
- General meeting, 2023-05-04
- Auditor reappointment, commissaire, 2026
03-07
State Gazette act
Resignations & appointmentsBoard meeting · Permanent representative2 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Permanent representative2 facts ▸
- Board meeting, 2024-04-29
- Permanent representative, Ine Nuyts
30-05
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
01-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
03-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
04-01
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment13 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment13 facts ▸
- General meeting, 2021-12-07
- Director resignation, Michel Detheux (administrateur)
- Director resignation, Gregory Driessens (administrateur)
- Director resignation, Olivier De Henau (administrateur)
- Director appointment, Philippe Brantegem (administrateur)
- Director appointment, Gilles Castaigne (administrateur)
- Director appointment, Benoit Dethy (administrateur)
- Board meeting, 2021-12-10
- Director resignation, Michel Detheux (administrateur délégué)
- Director appointment, Philippe Brantegem (administrateur délégué)
- Power of attorney, Olivier De Henau
- Power of attorney, Sandrine Segura
- +1 further facts in this act
2021
31-12
Financial
Back to profitnet €258.82M
Net result €258.82M after 3 loss-making years.
31-12
Financial
Equity above €250MEq €296.40M ▲750%
Equity rises from €34.85M to €296.40M.
21-09
State Gazette act
Resignations & appointmentsBoard meeting · Power of attorney7 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Power of attorney7 facts ▸
- Board meeting, 2021-02-04
- Power of attorney, Michel Detheux
- Power of attorney, Gilles Castaigne
- Power of attorney, Philippe Brantegem
- Power of attorney, Yvonne McGrath
- Power of attorney, Enza Sciagura
- Power of attorney, Maryse Brait
04-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
09-04
State Gazette act
Resignations & appointmentsBoard meeting · Power of attorney · Power-of-attorney revocation17 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Power of attorney · Power-of-attorney revocation17 facts ▸
- Board meeting, 2020-09-17
- Power of attorney, Michel Detheux
- Power of attorney, Gilles Castaigne
- Power of attorney, Philippe Brantegem
- Power of attorney, Enza Sciagura
- Power of attorney, Maryse Brait
- Power of attorney, Yvonne McGrath
- Power-of-attorney revocation, tous les pouvoirs spécifiques déterminés par le Conseil du 4 octobre 2018
- Delegation authorization, peut déléguer à une ou plusieurs personne(s) les pouvoirs spécifiques sous sa propre responsabilité
- Delegation authorization, peut déléguer à une ou plusieurs personne(s) les pouvoirs spécifiques sous sa propre responsabilité
- Delegation prohibition, ne sera autorisée à déléguer aucun des pouvoirs spécifiques énumérés
- Delegation prohibition, ne sera autorisée à déléguer aucun des pouvoirs spécifiques énumérés
- +5 further facts in this act
2020
23-06
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor reappointment2 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor reappointment2 facts ▸
- General meeting, 2020-05-07
- Auditor reappointment, commissaire, 2023
07-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
23-03
State Gazette act
Statutes amendment · Resignations & appointmentsGeneral meeting · Name change · Capital10 facts ▸
State Gazette act
Statutes amendment · Resignations & appointments
General meeting · Name change · Capital10 facts ▸
- General meeting, 2020-03-02
- Name change, iTeos Belgium SA
- Capital, €9.133.515,57
- Corporate purpose, La Société a pour objet, en Belgique et à l'étranger, tant pour son compte propre que pour compte de tiers ou en participation avec des tiers: -la recherche de…
- Director resignation, iTeos Therapeutics (administrateur)
- Director appointment, Gregory Driessens (administrateur)
- Director appointment, Olivier Pierre De Henau (administrateur)
- Share class unification, Unification des différentes classes d'actions et suppression de tous droits spéciaux attachés aux différentes classes d'actions
- Share and warrant suppression, Suppression de l'ensemble des parts bénéficiaires et des warrants (notamment les warrants sur parts bénéficiaires, les warrants anti-dilution et les warrants d'…
- Capital increase authorization revocation, Suppression de l'autorisation au conseil d'administration d'augmenter le capital souscrit, conférée par l'assemblée générale extraordinaire du 11 juin 2018
2019
31-12
Financial
Equity above €25MEq €35.32M ▲54.2%
Equity rises from €22.91M to €35.32M.
31-05
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
29-05
State Gazette act
Capital & shares · Resignations & appointmentsBoard meeting · Capital increase · Bank account5 facts ▸
State Gazette act
Capital & shares · Resignations & appointments
Board meeting · Capital increase · Bank account5 facts ▸
- Board meeting, 2019-04-29
- Capital increase, €3.307.968,21
- Bank account, ING Belgique SA
- Capital, €9.133.515,57
- Statutes amendment
17-04
State Gazette act
Resignations & appointmentsBoard meeting · Power of attorney · Director resignation10 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Power of attorney · Director resignation10 facts ▸
- Board meeting, 2018-10-04
- Power of attorney, Michel Detheux
- Power of attorney, Yves Mertens
- Power of attorney, Valérie Chapelle
- Power of attorney, Marie Pussemier
- Power of attorney, Maryse Brait
- Power of attorney, Scott Chappel
- Board meeting, 2018-12-10
- Director resignation, Pienter-Jan BVBA (administrateur)
- Director resignation, MG6A Bioconsulting SPRL (administrateur)
2018
03-07
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointmentsGeneral meeting · Capital increase · Share issue30 facts ▸
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointments
General meeting · Capital increase · Share issue30 facts ▸
- General meeting, 2018-06-08
- Capital increase, €286.740,06
- Capital increase, €3.356.198,79
- Capital increase, €0,02
- Share issue, Warrants sur parts bénéficiaires convertibles, 4454244
- Share issue, Warrants anti-dilution de Série B, 18
- Share issue, Warrants d'indemnisation, 18
- Statutes amendment, 5
- Statutes amendment, 5 bis
- Statutes amendment, 12
- Statutes amendment, 27
- Statutes amendment, 34
- +18 further facts in this act
01-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
29-05
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment3 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment3 facts ▸
- General meeting, 2018-05-03
- Director reappointment, Jean-Pierre Bizarri (administrateur)
- Director reappointment, Bruno Montanari (administrateur)
2017
02-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
26-05
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment · Auditor appointment14 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment · Auditor appointment14 facts ▸
- General meeting, 2017-05-04
- Director reappointment, PhG Bioconsulting SASU (administrateur)
- Director reappointment, Jonathan Skipper (administrateur)
- Director reappointment, Benoît Van den Eynde (administrateur)
- Director reappointment, Sopartec SA (administrateur)
- Director reappointment, Pienter-Jan BVBA (administrateur)
- Director reappointment, MG6A Bioconsulting SPRL (administrateur)
- Director reappointment, PhG Bioconsulting SASU (administrateur-délégué)
- Director reappointment, Jonathan Skipper (administrateur-délégué)
- Director reappointment, Benoît Van den Eynde (administrateur-délégué)
- Director reappointment, Sopartec SA (administrateur-délégué)
- Director reappointment, Pienter-Jan BVBA (administrateur-délégué)
- +2 further facts in this act
19-04
State Gazette act
Capital & sharesPower of attorney · Statute coordination2 facts ▸
State Gazette act
Capital & shares
Power of attorney · Statute coordination2 facts ▸
- Power of attorney
- Statute coordination, coordination des statuts
2016
21-12
State Gazette act
Registered officeBoard meeting · Registered-office move2 facts ▸
State Gazette act
Registered office
Board meeting · Registered-office move2 facts ▸
- Board meeting, 29/11/2016
- Registered-office move, Rue des Frères Wright, 29 - 6041 Gosselies
06-06
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor reappointment2 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor reappointment2 facts ▸
- General meeting, 2016-05-18
- Auditor reappointment, commissaire, 3 ans
15-03
State Gazette act
Capital & sharesShare issue1 fact ▸
State Gazette act
Capital & shares
Share issue1 fact ▸
- Share issue, stock option warrants
2015
18-12
State Gazette act
Resignations & appointments · MiscellaneousGeneral meeting · Director appointment · Mandate compensation4 facts ▸
State Gazette act
Resignations & appointments · Miscellaneous
General meeting · Director appointment · Mandate compensation4 facts ▸
- General meeting, 2015-11-25
- Director appointment, Jean-Pierre Bizzari (administrateur indépendant)
- Mandate compensation, Jean-Pierre Bizzari
- Share issue, 206554, Stock Option Warrants
26-06
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment3 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment3 facts ▸
- General meeting, 2015-05-07
- Director resignation, Hunza Management (administrateur)
- Director appointment, Bruno Montanari (administrateur indépendant)
08-04
State Gazette act
MiscellaneousGeneral meeting · Share issue2 facts ▸
State Gazette act
Miscellaneous
General meeting · Share issue2 facts ▸
- General meeting, 2014-12-16
- Share issue, droits de souscription sur des parts bénéficiaires (Stock Option Warrants), 159509
23-01
State Gazette act
Capital & shares · Statutes amendmentGeneral meeting · Capital · Capital increase7 facts ▸
State Gazette act
Capital & shares · Statutes amendment
General meeting · Capital · Capital increase7 facts ▸
- General meeting, 2014-12-16
- Capital, €2.182.608,49
- Capital increase, €111.110,05
- Bank account, compte spécial ouvert au nom de la société
- Share issue, Warrants Anti-dilution de Série A, 2
- Share issue, droits de souscription sur des parts bénéficiaires (Stock Option Warrants), 159509
- Statutes amendment
2013
27-05
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor appointment · Director resignation7 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor appointment · Director resignation7 facts ▸
- General meeting, 2013-05-02
- Auditor appointment, Michel Denis SCPRL (commissaire)
- Director resignation, Michel Detheux (administrateur)
- Director appointment, MG6A BioConsulting SPRL (administrateur)
- Director appointment, MG6A BioConsulting SPRL (administrateur délégué)
- Permanent representative, Michel Denis (commissaire de Iteos Therapeutics)
- Permanent representative, Michel Detheux (administrateur et administrateur délégué de Iteos Therapeutics)
2012
05-06
State Gazette act
Registered office · Capital & shares · Statutes amendment · Resignations & appointmentsGeneral meeting · Registered-office move · Share issue22 facts ▸
State Gazette act
Registered office · Capital & shares · Statutes amendment · Resignations & appointments
General meeting · Registered-office move · Share issue22 facts ▸
- General meeting, 2012-04-27
- Registered-office move, 6041 Gosselies, rue Auguste Piccard, 48
- Share issue, Warrants Anti-dilution de Série A, 10
- Share issue, Stock Option Warrants, 211306
- Capital increase, €2.009.998,44
- Bank account, Belfius Banque, BE 96 0688 9473 5505
- Director appointment, Jonathan SKIPPER (administrateur)
- Director appointment, Benoît VAN DEN EYNDE (administrateur)
- Director appointment, SOPARTEC (administrateur)
- Permanent representative, Philippe DURIEUX
- Director appointment, Pienter-Jan (administrateur)
- Permanent representative, Chris BUYSE
- +10 further facts in this act
72.9% of this act was read; anything after the cut is not in this list.Read the act at the Belgisch Staatsblad ↗
2011
18-08
State Gazette act
IncorporationIncorporation · Founding capital · Corporate purpose8 facts ▸
State Gazette act
Incorporation
Incorporation · Founding capital · Corporate purpose8 facts ▸
- Incorporation, 2011-08-01
- Founding capital, €61.500
- Corporate purpose, La société a pour objet, en Belgique et à l'étranger, tant pour son compte propre que pour compte de tiers en participation avec des tiers: - la recherche de la…
- Director appointment, VAN DEN EYNDE Benoît Jean Marie Henri (administrateur)
- Director appointment, DETHEUX Michel Marcel Alfred Pierre (administrateur)
- Mandate compensation, VAN DEN EYNDE Benoît Jean Marie Henri
- Mandate compensation, DETHEUX Michel Marcel Alfred Pierre
- First fiscal year, 2012-12-31, 2011-08-01
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
35 directors, last change in 2026
Michael Hearne
CurrentChief financial officer, treasurer and secretary · since 26-04-2026
Michel Detheux
CurrentChief executive officer · since 26-04-2026
Ryan Cole
CurrentChief operating officer · since 26-04-2026
Stew Kroll
CurrentChief development officer · since 26-04-2026
Thomas Wei
CurrentChief business officer · since 26-04-2026
Kevin Tang
CurrentDirector · since 29-08-2025
+ 16 not shown in this overview
26-04-2026
Michael Hearne: Appointed as Chief financial officer, treasurer and secretary
26-04-2026
Michel Detheux: Appointed as Chief executive officer
26-04-2026
Ryan Cole: Appointed as Chief operating officer
26-04-2026
Stew Kroll: Appointed as Chief development officer
26-04-2026
Thomas Wei: Appointed as Chief business officer
29-08-2025
Kevin Tang: Appointed as Director
29-08-2025
Michael Haerne: Appointed as Director
29-08-2025
Benoit Dethy: Resigned as Director
29-08-2025
Philippe Brantegem: Resigned as Director
14-08-2025
Gilles Castaigne: Resigned as Director
10-12-2021
Philippe Brantegem: Appointed as Managing director
07-12-2021
Michel Detheux: Resigned as Managing director
07-12-2021
Michel Detheux: Resigned as Director
07-12-2021
Benoit Dethy: Appointed as Director
07-12-2021
Philippe Brantegem: Appointed as Director
07-12-2021
Gilles Castaigne: Appointed as Director
07-12-2021
Gregory Driessens: Resigned as Director
07-12-2021
Olivier De Henau: Resigned as Director
02-03-2020
Olivier Pierre De Henau: Appointed as Director
02-03-2020
Gregory Driessens: Appointed as Director
11-06-2018
MG6A Bioconsulting SPRL: Resigned as Director
11-06-2018
Pienter-Jan BVBA: Resigned as Director
08-06-2018
Michel Detheux: Appointed as Director
08-06-2018
Ansbert Gadicke: Appointed as Director
+ 39 not shown in this overview
Not every act has been read: a resignation may be missing here
1 act was read only in part. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Charleroi · 2 establishment units since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Venise 216040 CharleroiGround area
1.5 ha
Building footprint
1,185 m²
Volume, LiDAR
22,563 m³
2 parcels, Wallonia · tallest building 23.7 m, ±6 floors. Linked by address, not a title deed.
2 establishment units
Rue des Frères Wright 29, 6041 Charleroi
since 20112.201.577.920
Rue Clément Ader 10, 6041 Charleroi
since 20232.353.232.371
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0295/02C000 | Wallonia | 7,830 m² | - | - |
| 52028B0318/00V000 | Wallonia | 7,219 m² | 1 · 1,185 m² | 23.7 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via establishment units: 2
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
5 auditors| Deloitte Bedrijfsrevisoren/Réviseurs d'EntreprisesCurrent Commissaire · represented by Koen Neijens | 04-05-2017 → present |
Show 4 earlier auditors
| DELOITTE Réviseurs d'Entreprises secrl Auditor | 25-05-2018 → 03-07-2018 |
| Denis, Michel Commissaire succeeded by DELOITTE Réviseurs d'Entreprises secrl in 2018 | 18-05-2016 → 25-05-2018 |
| Michel Denis Reviseur d'Entreprises SPRLU Auditor | 25-05-2018 → 03-07-2018 |
| Michel Denis SCPRL Commissaire · represented by Michel Denis succeeded by Denis, Michel in 2016 | 02-05-2013 → 18-05-2016 |
Structure & network
Connections & network
19 connected companiesNetwork connections
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Show 15 more network connections
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Ownership & control
1 partyControl over this companysits on this company's board1
10 subsidiaries · 2 locations
controls
iTeos BelgiumBE 0838.316.659
Capital and shareholders
Capital increase of 3,307,968.21 EUR · 10,042,405 new shares
Capital increase of 286,740.06 EUR · 857,982 new shares
Capital increase of 3,356,198.79 EUR · 10,042,394 new shares
Capital increase of 0.02 EUR · 251,934 new shares
Capital increase of 111,110.05 EUR · 332,463 new shares
Capital increase of 2,009,998.44 EUR · 5,583,329 new shares
Founding capital 61,500 EUR · 615,000 shares
Public money · subsidies and aid
European research
1 project · 949,030 EUR EU contributionProgrammes
h2020
Projects
Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy
Recognitions · licences · registrations
Legal Entity Identifier
549300CXW4EOC5GMB678
Similar companies · same sector, comparable size
Ncardia Holding
BE 0565.979.162
Mont-Saint-Guibert · Eq €98.82M
TELIX INNOVATIONS
BE 0627.636.718
Herstal · Eq €116.66M
DEVGEN
BE 0461.432.562
Gent · Eq €128.32M
Legend Biotech Belgium
BE 0769.992.730
Gent · Eq €62.87M
MDxHealth
BE 0479.292.440
Herstal · Eq €133.99M
Of 761 companies in sector 72101 we hold annual accounts for 481. 38 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded01-08-2011
Fiscal year end31-12
Abbreviation FR
ITEOS
Activities, NACEBEL
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.